RELAY: safety and efficacy of ramucirumab plus erlotinib in elderly Japanese patients with metastatic <i>EGFR</i> -mutated NSCLC

20250 citationsJournal Articlegreen Open Access

Authors

www.clinicaltrials.gov identifier is NCT02411448.

Published in: Future Oncology

Volume 21, Issue 24, pp. 3197-3206

Field-Weighted Citation Impact: 0.00